Key result
Positron emission tomography (PET) imaging provides valuable metabolic data for diagnosing, grading, staging, and assessing treatment response in patients with sarcoma.
PET imaging provides valuable metabolic data for the diagnosis, staging, and management of non-GIST sarcomas.
Authors
No takes yet. Share an insight, caveat, or question.
May support PET in sarcoma evaluation; leaves open need for prospective trials before routine adoption.
Toner et al. (2008) conducted a review in Sarcoma. Positron emission tomography (PET) was evaluated. Positron emission tomography (PET) imaging provides valuable metabolic data for diagnosing, grading, staging, and assessing treatment response in patients with sarcoma.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: